Reports without reliable country information are labeled as country not specified. PulseGLP analyzed 90 relevance-ranked patient reports across GLP-1, Semaglutide, Mounjaro from r/GLP1, r/Semaglutide, r/Mounjaro. The strongest structured pattern in this sample is symptom: Other, appearing in 10 extracted reports. The matching posts skew Analytical, Neutral-Low, Risk-Alert. This is a matched-sample finding, not a population-wide prevalence estimate.
Share of structured matched reports; this is not a population prevalence estimate.
"Thanks for posting to r/semaglutide ! A brief reminder about our rules. We do not permit the discussion of non-FDA approved formulations of semaglutide, nor do we permit selling or offering for sale any medication, including by private message."
Patient · Semaglutide · r/Semaglutide · United States
"Thanks for posting to r/semaglutide ! A brief reminder about our rules. We do not permit the discussion of non-FDA approved formulations of semaglutide, nor do we permit selling or offering for sale any medication, including by private message."
Patient · Semaglutide · r/Semaglutide · United States
"I’m curious as what they’d switch you to because people don’t usually lose faster on semaglutide medications. Tirzepatide medications are the quickest we currently have as Reta isn’t available yet as it’s not FDA approved. I’m not promoting 🩶."
Patient · Mounjaro · r/Mounjaro · United States
"Thanks for posting to r/semaglutide ! A brief reminder about our rules. We do not permit the discussion of non-FDA approved formulations of semaglutide, nor do we permit selling or offering for sale any medication, including by private message."
Patient · Semaglutide · r/Semaglutide · United States
Sourced from GLP-1 patient communities · See community discussion →
Published: · Updated: